Galapagos and @GileadSciences announce top-line results from Phase 3 SELECTION trial of investigational treatment in ulcerative colitis. Read more here: https://t.co/MprtjSWASw #UlcerativeColitis#UC
📰 Press Release: “On track for clinical read-outs and commercial readiness in 2020”. $GLPG Q1 results for 2020 are available! Read more: https://t.co/MprtjSWASw
@FranckenTheo Zou u zich niet beter bezig houden met de fietspaden in Lubbeek? Lubbeek heeft al jaren de slechtste en gevaarlijkste fietspaden (als die er al zijn) van Vlaanderen en u heeft er als burgemeester nog niets aan gedaan.
https://t.co/pfYOsIHrrS
The years 1932 to 1937 were years of depression in the United States. These stock market years were great with hundreds of percent profit! Lesson: the bottom of the stock market is not at the moment when the economy has bottomed, but when everyone has finished panic selling.
Fear can take mkt lower, but expect quick recovery when health threat recedes. Esp in US, underlying economy strong, banks well-capped, system not too leveraged. Unlike ‘08, will avoid systemic damage that cud take years to work thru. Obviously, not ignoring tragic human toll....
#Galapagos now is the most valuable European biotech with almost $15 billion in market cap. I have said for many years that this position was our ambition, and I want to thank all colleagues for making this happen. And as I keep repeating, ‘it is just the beginning’.
@BertBrijs@GuillaumeVdS Jammer dat telkens als het debat inhoudelijk wordt gevoerd men terug valt tot oneliners als ‘succes er mee’. Dat is wat politiek ook zowat geworden is: populistische oneliners die aan de toog van café Onder Den Toren makkelijk na te papegaaien zijn.
📰 Our partner @GileadSciences announced today that it has submitted an NDA with a priority review voucher to the @US_FDA for an investigational, oral, selective JAK1 inhibitor for the treatment of adults living with moderate-to-severe #RA. Press release: https://t.co/cQFTAZP865